Select Bibliography

Filter by any of these (after searching):

Loprinzi, C

There are 114 items

Genetic Predictors of Chemotherapy-Induced Peripheral Neuropathy from Paclitaxel, Carboplatin and Oxaliplatin: NCCTG/Alliance N08C1, N08CA and N08CB Study.

Adjei, Araba A , Lopez, Camden L , Schaid, Daniel J , Sloan, Jeff A ... - - Cancers (Basel) - 2021

Manuscript - Secondary-not-in-original - Primary - Symptom Inter - N08C1 , N08CA , N08CB

Cisplatin-associated neuropathy characteristics compared to those associated with other neurotoxic chemotherapy agents (Alliance A151724)

Albany, Costantine , Dockter, Travis , Wolfe, Eric ... - - Support Care Cancer - 2021

Manuscript - Primary - Primary - Symptom Inter - A151724

Using the Skindex-16 and CTCAE to assess rash symptoms: Results of a pooled-analysis (N0993).

Atherton, P. , Burger, K. , Loprinzi, C. , Miller, R. , Jatoi, A. ... - - J. Clin. Oncol. - 2010

Abstract - Primary - Primary - Symptom Inter - NCCTG-N0993

Using the Skindex-16 and Common Terminology Criteria for Adverse Events to assess rash symptoms: results of a pooled-analysis (N0993)

Atherton, Pamela J. , Burger, Kelli N. , Loprinzi, Charles L. ... - - Support Care Cancer - 2012

Manuscript - Primary - Primary - Symptom Inter - N0993

Adjuvant chemotherapy for resected stage II and III colon cancer: Comparison of widely used two prognostic calculators

Bardia, A. , Loprinzi, C. , Grothey, A. , Nelson, G. , Alberts, S. ... - - J. Clin. Oncol. - 2009

Abstract - Secondary-not-in-original - Primary - GI - NCCTG-N0148

Adjuvant Chemotherapy for Resected Stage II and III Colon Cancer: Comparison of Two Widely Used Prognostic Calculators

Bardia, Aditya , Loprinzi, Charles , Grothey, Axel , Nelson, Garth ... - - Semin Oncol - 2010

Manuscript - Secondary-not-in-original - Primary - GI - N0148

The use of Valeriana officinalis (Valerian) in improving sleep in patients who are undergoing treatment for cancer: a phase III randomized, placebo-controlled, double-blind study (NCCTG Trial, N01C5)

Barton, D. L. , Atherton, P. J. , Bauer, B. A. , Moore, D. F. Jr ... - - J Support Oncol - 2011

Manuscript - Primary - Primary - Symptom Inter - N01C5

Phase III, placebo-controlled trial of three doses of citalopram for the treatment of hot flashes: NCCTG trial N05C9

Barton, D. L. , Lavasseur, B. I. , Sloan, J. A. , Stawis, A. N. ... - - J. Clin. Oncol. - 2010

Manuscript - Primary - Primary - Symptom Inter - N05C9

Phase III evaluation of American ginseng (panax quinquefolius) to improve cancer-related fatigue: NCCTG trial N07C2

Barton, D. L. , Liu, H. , Dakhil, S. R. , Linquist, B. M. ... - - J. Clin. Oncol. - 2012

Abstract - Primary - Primary - Symptom Inter - N07C2

Wisconsin ginseng (Panax quinquefolius) to improve cancer-related fatigue: A randomized, double-blind trial, N07C2

Barton, D. L. , Liu, H. , Dakhil, S. R. , Linquist, B. , Sloan, J. A. ... - - J. Natl. Cancer Inst. - 2013

Manuscript - Primary - Primary - Symptom Inter - N07C2

Can gabapentin improve control of delayed nausea and vomiting (N/V)? A phase III placebo controlled trial, N08C3 (Alliance)

Barton, D. L. , Sloan, J. A. , Novotny, P. J. , Fuloria, J. ... - - Support Care Cancer - 2013

Abstract - Primary - Primary - Symptom Inter - N08C3

Does gabapentin prevent delayed chemotherapy-induced nausea and vomiting (N/V)? Results of a randomized placebo controlled trial, NCCTG N08C3 (Alliance)

Barton, D. L. , Sloan, J. A. , Novotny, P. J. , Fuloria, J. ... - - J. Clin. Oncol. - 2013

Abstract - Primary - Primary - Symptom Inter - N08C3

A pilot, multi-dose, placebo-controlled evaluation of american ginseng (panax quinquefolius) to improve cancer-related fatigue: NCCTG trial N03CA

Barton, D. L. , Soori, G. S. , Bauer, B. , Sloan, J. , Johnson, P. A. ... - - J. Clin. Oncol. - 2007

Abstract - Primary - Primary - Symptom Inter - N03CA

A double-blind, placebo-controlled trial of a topical treatment for chemotherapy-induced peripheral neuropathy: NCCTG trial N06CA

Barton, D. L. , Wos, E. J. , Qin, R. , Mattar, B. I. , Green, N. B. ... - - Support Care Cancer - 2011

Manuscript - Primary - Primary - Symptom Inter - N06CA

A randomized controlled trial evaluating a topical treatment for chemotherapy-induced neuropathy: NCCTG trial N06CA

Barton, D. L. , Wos, E. , Qin, R. , Mattar, B. , Green, N. , Lanier, K. ... - - J. Clin. Oncol. - 2009

Abstract - Primary - Primary - Symptom Inter - N06CA

Adiponectin: A novel biomarker for cancer- related fatigue?; NCCTG study N07C2 (Alliance)

Barton, D. , Liu, H. , Tan, A. , Sloan, J. ... - MASCC / ISOO - Support Care Cancer - 2013

Abstract - Secondary - Primary - Symptom Inter - N07C2

The use of Ginkgo biloba for the prevention of chemotherapy-related cognitive dysfunction in women receiving adjuvant treatment for breast cancer, N00C9

Barton, Debra L. , Burger, Kelli , Novotny, Paul J. , Fitch, Tom R. ... - - Support Care Cancer - 2013

Manuscript - Primary - Primary - Symptom Inter - N00C9

Systemic and local effects of vaginal dehydroepiandrosterone (DHEA): NCCTG N10C1 (Alliance)

Barton, Debra L. , Shuster, Lynne T. , Dockter, Travis ... - - Support Care Cancer - 2018

Manuscript - Secondary - Primary - Symptom Inter - N10C1

Evaluating the efficacy of vaginal dehydroepiandosterone for vaginal symptoms in postmenopausal cancer survivors: NCCTG N10C1 (Alliance)

Barton, Debra L. , Sloan, Jeff A. , Shuster, Lynne T. , Gill, Paula ... - - Support Care Cancer - 2018

Manuscript - Primary - Primary - Symptom Inter - N10C1

Impact of vaginal dehydroepiandosterone (DHEA) on vaginal symptoms in female cancer survivors: Trial N10C1 (Alliance)

Barton, Debra L. , Sloan, Jeff A. , Shuster, Lynne T , Gill, Paula ... - ASCO - J. Clin. Oncol. - 2014

Abstract - Primary - Primary - Symptom Inter - N10C1

Pilot study of Panax quinquefolius (American ginseng) to improve cancer-related fatigue: a randomized, double-blind, dose-finding evaluation: NCCTG trial N03CA

Barton, Debra L. , Soori, Gamini S. , Bauer, Brent A. ... - - Support Care Cancer - 2010

Manuscript - Primary - Primary - Symptom Inter - N03CA

Phase III Double-Blind, Placebo-Controlled Study of Gabapentin for the Prevention of Delayed Chemotherapy-Induced Nausea and Vomiting in Patients Receiving Highly Emetogenic Chemotherapy, NCCTG N08C3 (Alliance)

Barton, Debra L. , Thanarajasingam, Gita , Sloan, Jeff A. ... - - Cancer - 2014

Manuscript - Primary - Primary - Symptom Inter - N08C3

A randomized phase II trial evaluating two non-pharmacologic interventions in cancer survivors for the treatment of sleep-wake disturbances: NCCTG N07C4 (Alliance)

Barton, Debra L , Atherton, Pamela J , Satele, Daniel V , Qin, Rui ... - - Support Care Cancer - 2020

Manuscript - Primary - Primary - Symptom Inter - NCCTG-N07C4

Randomized controlled trial to evaluate transdermal testosterone in female cancer survivors with decreased libido; North Central Cancer Treatment Group protocol N02C3.

Barton, Debra L , Wender, Donald B , Sloan, Jeff A , Dalton, Robert J ... - - J. Natl. Cancer Inst. - 2007

Manuscript - Primary - Primary - Symptom Inter - NCCTG-N02C3

Sequencing symptom control: Results from the Alliance N08C1 and N08CA genetics of chemotherapy neuropathy trials

Beutler, A. S. , Kulkarni, A. , Kanwar, R. , Qin, R. ... - AACR - AACR 2013 Annual Meeting - 2013

Abstract - Secondary-not-in-original - Primary - Symptom Inter - N08C1 , N08CA

Sequencing of Charcot-Marie-Tooth disease genes in a toxic polyneuropathy

Beutler, Andreas S. , Kulkarni, Amit A. , Kanwar, Rahul ... - - Ann. Neurol. - 2014

Manuscript - Secondary-not-in-original - Meta-Analysis - Symptom Inter - N08C1 , N08CA

Testing of candidate single nucleotide variants associated with paclitaxel neuropathy in the trial NCCTG N08C1 (Alliance)

Boora, Ganesh K. , Kanwar, Rahul , Kulkarni, Amit A. , Abyzov, Alexej ... - - Cancer Med - 2016

Manuscript - Secondary-not-in-original - Primary - Symptom Inter - N08C1

Association of the Charcot-Marie-Tooth disease gene ARHGEF10 with paclitaxel induced peripheral neuropathy in NCCTG N08CA (Alliance)

Boora, Ganesh K. , Kulkarni, Amit A. , Kanwar, Rahul ... - - J. Neurol. Sci. - 2015

Manuscript - Secondary-not-in-original - Primary - Symptom Inter - N08CA

Assessment of long-term rectal function in patients who received pelvic radiotherapy: a pooled North Central Cancer Treatment Group trial analysis, N09C1

Brown, L. C. , Atherton, P. J. , Neben-Wittich, M. A. , Wender, D. B. ... - - Support Care Cancer - 2013

Manuscript - Secondary - Primary - Health Outcome - N09C1

A randomized, double-blind, placebo-controlled trial of testosterone for treatment of postmenopausal women with aromatase inhibitor-induced arthralgias: Alliance study A221102

Cathcart-Rake, Elizabeth , Novotny, Paul , Leon-Ferre, Roberto ... - - Support Care Cancer - 2021

Manuscript - Primary - Primary - Symptom Inter - A221102

Use of a lidocaine patch in the management of postsurgical neuropathic pain in patients with cancer: a phase III double-blind crossover study (N01CB)

Cheville, Andrea L. , Sloan, Jeff A. , Northfelt, Donald W. ... - - Support Care Cancer - 2009

Manuscript - Primary - Primary - Symptom Inter - N01CB

Randomized comparison of a nicotine inhaler and bupropion for smoking cessation and relapse prevention.

Croghan, Ivana T , Hurt, Richard D , Dakhil, Shaker R ... - - Mayo Clin. Proc. - 2007

Manuscript - Primary - Primary - Prevention - NCCTG-N99C4

A Pilot Randomized, Placebo Controlled, Double Blind Study of Omega-3 Fatty Acids to Prevent Paclitaxel Associated Acute Pain Syndrome

Dayao, Zoneddy , Brown-Glabermann, Ursa , Chen, Lu , Pankratz, Shane ... - ASCO - J Clin Oncol - 2020

Abstract - Primary - Primary - Symptom Inter - Pilot

Endpoint comparison for bone mineral density measurements in North Central Cancer Treatment Group cancer clinical trials N02C1 and N03CC (Alliance)

Dueck, A. C. , Singh, J. , Atherton, P. , Liu, H. , Novotny, P. ... - - Osteoporos Int - 2015

Manuscript - Secondary-not-in-original - Primary - Health Outcome - N02C1 , N03CC

Analysis of prognostic (prog) Web-based models for stage II and III colon cancer (CC): A population-based validation of Numeracy (NUM) and ADJUVANT! Online (ADJ!).

Gill, S. , Loprinzi, C. , Kennecke, H. , Grothey, A. , Nelson, G. ... - - J. Clin. Oncol. - 2009

Abstract - Secondary-not-in-original - Comprehensive - GI - N0148

Prognostic Web-based Models for Stage II and III Colon Cancer: a Population and Clinical Trials-based Validation of Numeracy and Adjuvant! Online

Gill, Sharlene , Loprinzi, Charles , Kennecke, Hagen , Grothey, Axel ... - - Cancer - 2011

Manuscript - Secondary-not-in-original - Meta-Analysis - GI - NCCTG-89-46-51 , NCCTG-914653

Intravenous Calcium and Magnesium for Oxaliplatin-Induced Sensory Neurotoxicity in Adjuvant Colon Cancer: NCCTG N04C7

Grothey, Axel , Nikcevich, Daniel A. , Sloan, Jeff A. ... - - J Clin Oncol - 2011

Manuscript - Primary - Primary - Symptom Inter - N04C7

Effect of Longer-Interval vs Standard Dosing of Zoledronic Acid on Skeletal Events in Patients With Bone Metastases

Himelstein, Andrew L. , Foster, Jared C. , Khatcheressian, James L. ... - - JAMA - 2017

Manuscript - Primary - Primary - Symptom Inter - CALGB-79804 , CALGB-70604 , CALGB-150804

CALGB 70604 (Alliance): A randomized phase III study of standard dosing vs. longer interval dosing of zoledronic acid in metastatic cancer

Himelstein, Andrew L. , Qin, Rui , Novotny, Paul J. ... - ASCO - J. Clin. Oncol. - 2015

Abstract - Primary - Primary - Symptom Inter - CALGB-70604

Immediate versus delayed zoledronic acid for prevention of bone loss in postmenopausal women with breast cancer starting letrozole after tamoxifen-N03CC

Hines, Stephanie L. , Mincey, Betty , Dentchev, Todor ... - - Breast Cancer Res. Treat. - 2009

Manuscript - Primary - Primary - Symptom Inter - N03CC

A double-blind, placebo-controlled randomized trial of creatine for the cancer anorexia/weight loss syndrome (N02C4): an Alliance trial.

Jatoi, A , Steen, P D , Atherton, P J , Moore, D F , Rowland, K M ... - - Ann. Oncol. - 2017

Manuscript - Primary - Primary - Symptom Inter - N02C4

Prophylactic Tetracycline Does Not Diminish the Severity of Epidermal Growth Factor Receptor (EGFR) Inhibitor Induced Rash: Results from the North Central Cancer Treatment Group (Supplementary N03CB)1

Jatoi, Aminah , Dakhil, Shaker R. , Sloan, Jeff A. , Kugler, John W. ... - - Support Care Cancer - 2011

Manuscript - Secondary - Primary - Symptom Inter - N03CB

A Pilot Study of Long-Acting Octreotide for Symptomatic Malignant Ascites (N04C2)

Jatoi, Aminah , Nieva, Jorge J. , Qin, Rui , Loprinzi, Charles L. ... - - Oncology - 2012

Manuscript - Primary - Primary - Symptom Inter - N04C2

A placebo-controlled, double-blind trial of infliximab for cancer-associated weight loss in elderly and/or poor performance non-small cell lung cancer patients (N01C9).

Jatoi, Aminah , Ritter, Howard L , Dueck, Amylou , Nguyen, Phuong L ... - - Lung Cancer - 2010

Manuscript - Primary - Primary - Symptom Inter - N01C9

Tetracycline to Prevent Epidermal Growth Factor Receptor Inhibitor-Induced Skin Rashes: Results of a Placebo-Controlled Trial from the North Central Cancer Treatment Group (N03CB)1

Jatoi, Aminah , Rowland, Kendrith , Sloan, Jeff A. , Gross, Howard M. ... - - Cancer - 2008

Manuscript - Primary - Primary - Symptom Inter - N03CB

Does Sunscreen Prevent Epidermal Growth Factor Receptor (EGFR) Inhibitor–Induced Rash? Results of a Placebo-Controlled Trial from the North Central Cancer Treatment Group (N05C4)

Jatoi, Aminah , Thrower, Abby , Sloan, Jeff A. , Flynn, Patrick J. ... - - Oncologist - 2010

Manuscript - Primary - Primary - Prevention - N05C4

Osteoporosis prevention in prostate cancer patients receiving androgen ablation therapy: placebo-controlled double-blind study of estradiol and risedronate: N01C8

Kearns, Ann E. , Northfelt, Donald W. , Dueck, Amylou C. ... - - Support Care Cancer - 2010

Manuscript - Primary - Primary - Symptom Inter - N01C8

The use of vitamin E for the prevention of chemotherapy-induced peripheral neuropathy: results of a randomized phase III clinical trial

Kottschade, Lisa A. , Sloan, Jeff A. , Mazurczak, Miroslaw A. ... - - Support Care Cancer - 2011

Manuscript - Primary - Primary - Symptom Inter - N05C3

Chemotherapy-induced nausea and vomiting: incidence and characteristics of persistent symptoms and future directions NCCTG N08C3 (Alliance)

Kottschade, Lisa , Novotny, Paul , Lyss, Alan , Mazurczak, Miroslaw ... - - Support Care Cancer - 2016

Manuscript - Secondary-not-in-original - Primary - Symptom Inter - N08C3

RWDD3 and TECTA variants not linked to paclitaxel induced peripheral neuropathy in North American trial N08C1

Kulkarni, Amit A. , Boora, Ganesh , Kanwar, Rahul , Ruddy, Kathryn J. ... - - Acta Oncol - 2015

Manuscript - Secondary-not-in-original - Primary - Symptom Inter - N08C1

Psychometric Testing of the European Organisation for Research and Treatment of Cancer (EORTC) QLQ-CIPN20 Using Pooled Chemotherapy-Induced Peripheral Neuropathy Outcome Measures Standardization (CI-PeriNomS) and Alliance for Clinical Trials in Oncology (Alliance) A151408 Study Data

Lavoie Smith, Ellen M. , Banerjee, Tanima , Yang, James J. ... - - Cancer Nurs - 2019

Manuscript - Secondary-not-in-original - Primary - Symptom Inter - A151408

Patient-Reported (EORTC QLQ-CIPN20) Versus Physician-Reported (CTCAE) Quantification of Oxaliplatin- and Paclitaxel/Carboplatin-Induced Peripheral Neuropathy in NCCTG/Alliance Clinical Trials

Le-Rademacher, Jennifer , Kanwar, Rahul , Seisler, Drew ... - - Support Care Cancer - 2017

Manuscript - Secondary-not-in-original - Meta-Analysis - Symptom Inter - N08CA , N08CB

NCCTG N08CA (Alliance): The use of Glutathione for Prevention of Paclitaxel/Carboplatin Induced Peripheral Neuropathy: A Phase III Randomized, Double-Blind Placebo-Controlled Study

Leal, Alexis D. , Qin, Rui , Atherton, Pamela J. , Haluska, Paul ... - - Cancer - 2014

Manuscript - Primary - Primary - Symptom Inter - N08CA

Doxepin Rinse Versus Placebo in the Treatment of Acute Oral Mucositis Pain in Patients Receiving Head and Neck Radiotherapy With or Without Chemotherapy: A Phase III, Randomized, Double-Blind Trial (NCCTG-N09C6 [Alliance])

Leenstra, James L. , Miller, Robert C. , Qin, Rui ... - - J. Clin. Oncol - 2014

Manuscript - Primary - Primary - Symptom Inter - N09C6

A randomized, double-blind, placebo-controlled trial of testosterone (T) for aromatase inhibitor-induced arthralgias (AIA) in postmenopausal women: Alliance study A221102

Leon-Ferre, Roberto A. , Novotny, Paul , Terstriep, Shelby ... - SABCS - Cancer Res - 2019

Abstract - Primary - Primary - Symptom Inter - A221102

Comparing and validating simple measures of patient-reported peripheral neuropathy (PRPN) for NCCTG Clinical Trials: A pooled analysis of 2,440 patients (pts)

Liu, H. , Tan, A. D. , Grothey, A. , Schaefer, P. L. , Buckner, J. C. ... - - J. Clin. Oncol. - 2008

Abstract - Secondary-not-in-original - Primary - Symptom Inter - N0897

A phase III randomized, double-blind, placebo-controlled study of pilocarpine for vaginal dryness: NCCTG study N04CA

Loprinzi, C. L. , Balcueva, E. P. , Liu, H. , Kottschade, L. A. ... - - J. Clin. Oncol. - 2010

Abstract - Primary - Primary - Symptom Inter - N04CA

A phase III randomized, double-blind, placebo-controlled study of pilocarpine for vaginal dryness: North Central Cancer Treatment group study N04CA

Loprinzi, C. L. , Balcueva, E. P. , Liu, H. , Sloan, J. A. ... - - J Support Oncol - 2011

Manuscript - Primary - Primary - Symptom Inter - N04CA

Gabapentin for hot flashes in men: NCCTG trial N00CB

Loprinzi, C. L. , Khoyratty, B. S. , Dueck, A. , Barton, D. L. ... - - J. Clin. Oncol. - 2007

Abstract - Primary - Primary - Symptom Inter - N00CB

Phase III randomized, placebo (PL)-controlled, double-blind study of intravenous calcium/magnesium (CaMg) to prevent oxaliplatin-induced sensory neurotoxicity (sNT), N08CB: An Alliance for Clinical Trials in Oncology study

Loprinzi, C. L. , Qin, R. , Dakhil, S. R. , Fehrenbacher, L. ... - - J. Clin. Oncol. - 2013

Abstract - Primary - Primary - Symptom Inter - N08CB

Pregabalin for hot flashes in women: NCCTG trial N07C1

Loprinzi, C. L. , Qin, R. , Stella, P. J. , Rowland, K. M., Jr ... - - J. Clin. Oncol. - 2009

Abstract - Primary - Primary - Symptom Inter - N07C1

Natural history of paclitaxel-associated acute pain syndrome: prospective cohort study NCCTG N08C1

Loprinzi, C. L. , Reeves, B. N. , Dakhil, S. R. , Sloan, J. A. ... - - J. Clin. Oncol. - 2011

Manuscript - Primary - Primary - Health Outcome - N08C1

Phase III, Randomized, Double-Blind, Placebo-Controlled Evaluation of Pregabalin for Alleviating Hot Flashes, N07C1

Loprinzi, Charles L. , Qin, Rui , Baclueva, Ernie P. ... - - J Clin Oncol - 2010

Manuscript - Primary - Primary - Symptom Inter - N07C1

Phase III Randomized, Placebo-Controlled, Double-Blind Study of Intravenous Calcium and Magnesium to Prevent Oxaliplatin-Induced Sensory Neurotoxicity (N08CB/Alliance)

Loprinzi, Charles L. , Qin, Rui , Dakhil, Shaker R. ... - - J. Clin. Oncol - 2014

Manuscript - Primary - Primary - Symptom Inter - N08CB

Phase III trial of gabapentin alone or in conjunction with an antidepressant in the management of hot flashes in women who have inadequate control with an antidepressant alone: NCCTG N03C5.

Loprinzi, Charles L , Kugler, John W , Barton, Debra L ... - - J. Clin. Oncol. - 2007

Manuscript - Primary - Primary - Symptom Inter - N03C5

Prevention of aromatase Inhibitor (AI)-induced joint symptoms with omega-3 fatty acid supplementation: A randomized placebo-controlled pilot study

Lustberg, M.B. , Orchard, T. , Pan, X. , Reinbolt, R. , Logan, A. ... - SABCS - Cancer Res - 2015

Abstract - Primary - Primary - Symptom Inter - NCT01478477

Randomized Placebo-Controlled Pilot Trial of Omega 3 Fatty Acids for Prevention of Aromatase Inhibitor-Induced Musculoskeletal Pain

Lustberg, Maryam B , Orchard, Tonya S. , Reinbolt, Raquel ... - - Breast Cancer Res. Treat. - 2018

Manuscript - Primary - Primary - Symptom Inter - NCT01478477

Primary and Secondary Endpoint Analysis of N08C9 (Alliance)- A Phase III Randomized Trial of Sulfasalazine versus Placebo in the Prevention of Acute Radiation Enteritis

Miller, R. C. , Petereit, D. G. , Sloan, J. A. , Liu, H. ... - ASCO GI - J. Clin. Oncol. - 2015

Abstract - Secondary - Primary - Symptom Inter - N08C9

Primary and Secondary Endpoint Analysis of N08C9 (Alliance)- A Phase III Randomized Trial of Sulfasalazine versus Placebo in the Prevention of Acute Radiation Enteritis

Miller, R. C. , Petereit, D. G. , Sloan, J. A. , Liu, H. ... - ASTRO - INT J RADIAT BIOL - 2014

Abstract - Secondary - Primary - Symptom Inter - N08C9

N08C9 (Alliance) - A Phase 3 Randomized Study of Sulfasalazine Versus Placebo in the Prevention of Acute Diarrhea in Patients Receiving Pelvic Radiation Therapy

Miller, R. C. , Petereit, D. G. , Sloan, J. A. , Liu, H. ... - ASTRO - Int. J. Radiat. Oncol. Biol. Phys. - 2013

Abstract - Primary - Primary - Symptom Inter - N08C9

N09C6 (Alliance) -A phase III, randomized double-blind study of N09C6 rinse versus placebo in the treatment of acute oral mucositis pain in patients receiving head and neck radiotherapy with or without chemotherapy

Miller, R. , Leenstra, J. , Qun, R. , Martenson, J. , Dornfeld, J. ... - - Int. J. Radiat. Oncol. Biol. Phys. - 2013

Abstract - Primary - Primary - Symptom Inter - N09C6

A Phase III, Randomized Double-Blind Study of Doxepin Rinse versus “Magic Mouthwash” versus Placebo in the Treatment of Acute Oral Mucositis Pain in Patients Receiving Head and Neck Radiotherapy with or without Chemotherapy (Alliance A221304)

Miller, Robert C. , Le-Rademacher, Jennifer , Sio, Terence ... - ASTRO - Int. J. Radiat. Oncol. Biol. Phys. - 2016

Abstract - Primary - Primary - Symptom Inter - A221304

N09C6 (Alliance) - A Phase III, Randomized Double-Blind Study of Doxepin Rinse versus Placebo in the Treatment of Acute Oral Mucositis Pain: Secondary analysis of the continuation phase

Miller, Robert C. , Leenstra, James L. , Qin, Rui ... - - European Journal of Cancer - 2013

Abstract - Primary - Primary - Symptom Inter - N09C6

N08C9 (Alliance): A Phase 3 Randomized Study of Sulfasalazine vs Placebo in the Prevention of Acute Diarrhea in Patients Receiving Pelvic Radiation Therapy

Miller, Robert C. , Petereit, Daniel G. , Sloan, Jeff A. ... - - Int. J. Radiat. Oncol. Biol. Phys. - 2016

Manuscript - Primary - Primary - Symptom Inter - N08C9

Mometasone Furoate Effect on Acute Skin Toxicity in Breast Cancer Patients Receiving Radiotherapy: A Phase 3 Double-Blind, Randomized Trial from the North Central Cancer Treatment Group N06C4

Miller, Robert C. , Schwartz, David J. , Sloan, Jeff A. ... - - Int J Radiat Oncol Biol Phys - 2011

Manuscript - Primary - Primary - Symptom Inter - N06C4

Gabapentin for the management of hot flashes in prostate cancer survivors: a longitudinal continuation Study-NCCTG Trial N00CB

Moraska, A. R. , Atherton, P. J. , Szydlo, D. W. , Barton, D. L. ... - - J Support Oncol - 2010

Manuscript - Primary - Primary - Symptom Inter - N00CB

Gabapentin for the management of hot flashes in prostate cancer survivors: A longitudinal continuation study—NCCTG trial N00CB

Moraska, A. R. , Atherton, P. J. , Szydlo, D. W. , Barton, D. L. ... - - J. Clin. Oncol. - 2010

Abstract - Primary - Primary - Symptom Inter - N00CB

Phase III, randomized, double-blind, placebo-controlled study of long-acting methylphenidate for cancer-related fatigue: North Central Cancer Treatment Group NCCTG-N05C7 trial

Moraska, A. R. , Sood, A. , Dakhil, S. R. , Sloan, J. A. , Barton, D. ... - - J. Clin. Oncol. - 2010

Manuscript - Primary - Primary - Symptom Inter - N05C7

Health-Related Quality of Life Outcomes for the LEAP Study - CALGB 70305 (Alliance): A Lymphedema Prevention Intervention Trial for Newly Diagnosed Breast Cancer Patients

Naughton, Michelle J. , Liu, Heshan , Seisler, Drew ... - - Cancer - 2021

Manuscript - Secondary - Primary - Health Outcome - CALGB-70305

A Placebo Controlled, Randomized, Double Blinded Trial of Olanzapine for the Treatment of Chronic Nausea and/or Vomiting, Unrelated to Chemotherapy/Radiation

Navari, RM , Pywell, C , Le-Rademacher, JG , White, AB Dodge PH ... - ASCO SCO - J Clin Oncol - 2019

Abstract - Primary - Primary - Symptom Inter - Pilot

Olanzapine for the Treatment of Advanced Cancer–Related Chronic Nausea and/or Vomiting

Navari, Rudolph M. , Pywell, Cameron M. , Le-Rademacher, Jennifer G. ... - - JAMA Oncol - 2020

Manuscript - Primary - Primary - Symptom Inter - Pilot , NCT03137121

Olanzapine for the Prevention of Chemotherapy-Induced Nausea and Vomiting

Navari, Rudolph M. , Qin, Rui , Ruddy, Kathryn J. , Liu, Heshan ... - - N. Engl. J. Med. - 2016

Manuscript - Primary - Primary - Symptom Inter - A221301

Olanzapine For The Prevention Of Chemotherapy Induced Nausea And Vomiting (CINV) In Patients Receiving Highly Emetogenic Chemotherapy (HEC): Alliance A221301 A Randomized, Double-Blind, Placebo-Controlled Trial

Navari, Rudolph M. , Qin, Rui , Ruddy, Kathryn J. , Liu, Heshan ... - ASCO Pal - J. Clin. Oncol. - 2015

Abstract - Primary - Primary - Symptom Inter - A221301

Comparison of provider-assessed and patient-reported outcome measures of acute skin toxicity during a phase III trial of mometasone cream versus placebo during breast radiotherapy: the North Central Cancer Treatment Group (N06C4)

Neben-Wittich, Michelle A. , Atherton, Pamela J. ... - - Int. J. Radiat. Oncol. Biol. Phys. - 2011

Manuscript - Secondary - Primary - Symptom Inter - N06C4

Randomized Clinical Trial of Imiquimod: An Adjunct to Treating Cervical Dysplasia

Pachman, Deirdre R. , Barton, Debra L. , Clayton, Amy H. ... - - Am J Obstet Gynecol - 2012

Manuscript - Primary - Primary - Prevention - NCCTG-989251

Clinical course of patients with oxaliplatin-associated neuropathy: N08CB (Alliance)

Pachman, Deirdre R. , Qin, Rui , Seisler, Drew K. ... - ASCO - J. Clin. Oncol. - 2014

Abstract - Secondary - Primary - Symptom Inter - N08CB

Clinical Course of Oxaliplatin-Induced Neuropathy: Results From the Randomized Phase III Trial N08CB (Alliance)

Pachman, Deirdre R. , Qin, Rui , Seisler, Drew K. , Smith, Ellen M.L. ... - - J. Clin. Oncol - 2015

Manuscript - Secondary - Primary - Symptom Inter - N08CB

Comparison of oxaliplatin and paclitaxel-induced neuropathy (Alliance A151505)

Pachman, Deirdre R. , Qin, Rui , Seisler, Drew ... - - Support Care Cancer - 2016

Manuscript - Primary - Primary - Symptom Inter - A151505 , N08C1 , N08CB

NCCTG N10C2 (Alliance) – A Double-Blind, Placebo-Controlled Study of Magnesium Supplements to Reduce Menopausal Hot Flashes

Park, Haeseong , Qin, Rui , Smith, Thomas J. , Atherton, Pamela J. ... - - Menopause - 2015

Manuscript - Primary - Primary - Symptom Inter - N10C2

NCCTG N10C2 (Alliance): A double-blind, placebo-controlled study of magnesium supplements to reduce menopausal hot flashes

Park, Haeseong , Qin, Rui , Smith, Thomas J. , Atherton, Pamela J. ... - ASCO - J. Clin. Oncol. - 2014

Abstract - Primary - Primary - Symptom Inter - N10C2

A randomized study to prevent lymphedema in women treated for breast cancer: CALGB 70305 (Alliance)

Paskett, Electra D. , Le-Rademacher, Jennifer , Oliveri, Jill M. ... - - Cancer - 2021

Manuscript - Primary - Primary - Symptom Inter - CALGB-70305

A Phase III randomized, double-blind placebo controlled study of armodafinil (nuvigil®) to reduce cancer-related fatigue in patients with high grade glioma (Alliance A221101)

Porter, Alyx B. , Kohli, Sadhna , Cerhan, Jane , Sloan, Jeff ... - ASCO - J Clin Oncol - 2020

Abstract - Primary - Primary - Symptom Inter - A221101

The evaluation of flaxseed for hot flashes: Results of a randomized, controlled trial, NCCTG study N08C7

Pruthi, S. , Qin, R. , Terstriep, S. A. , Liu, H. , Loprinzi, C. L. ... - - J. Clin. Oncol. - 2011

Abstract - Primary - Primary - Symptom Inter - N08C7

A Phase III, Randomized, Placebo-Controlled, Double-Blind Trial of Flaxseed for the Treatment of Hot Flashes1:NCCTG N08C7

Pruthi, Sandhya , Qin, Rui , Terstreip, Shelby A. , Liu, Heshan ... - - Menopause - 2012

Manuscript - Primary - Primary - Symptom Inter - N08C7

Pilot Study of Fractional CO2 Laser Therapy for Genitourinary Syndrome of Menopause in Gynecologic Cancer Survivors

Quick, Allison , Dockter, Travis , Le-Rademacher, Jennifer ... - - Maturitas - 2021

Manuscript - Primary - Primary - Symptom Inter - NCT03372720

Natural history of paclitaxel-associated acute pain syndrome (P-APS): NCCTG trial N08C1

Reeves, B. , Dakhil, S. R. , Sloan, J. A. , Kamal, A. , Wolf, S. L. ... - - J. Clin. Oncol. - 2010

Abstract - Primary - Primary - Health Outcome - N08C1

Further data supporting that paclitaxel-associated acute pain syndrome is associated with development of peripheral neuropathy: North Central Cancer Treatment Group trial N08C1.

Reeves, Brandi N , Dakhil, Shaker R , Sloan, Jeff A , Wolf, Sherry L ... - - Cancer - 2012

Manuscript - Secondary - Long-Term-Followup - Symptom Inter - N08C1

A Comparison of the Natural History of Oxaliplatin- and Paclitaxel-Induced Neuropathy (NCCTG N08C1, N08CB/Alliance)

Ruddy, Kathryn Jean , Pachman, Dierdre , Qin, Rui , Seisler, Drew K. ... - ASCO - J. Clin. Oncol. - 2015

Abstract - Primary - Primary - Symptom Inter - A151505 , N08C1 , N08CB

Predictors of duloxetine response in patients with oxaliplatin-induced painful chemotherapy-induced peripheral neuropathy (CIPN): a secondary analysis of randomised controlled trial – CALGB/alliance 170601

SMITH, E.M.L. , PANG, H. , YE, C. , CIRRINCIONE, C. , FLEISHMAN, S. ... - - Eur J Cancer Care (Engl) - 2017

Manuscript - Secondary-not-in-original - Primary - Health Outcome - CALGB-170601

A randomized trial of aspirin to prevent colorectal adenomas in patients with previous colorectal cancer.

Sandler, Robert S , Halabi, Susan , Baron, John A , Budinger, Susan ... - - N. Engl. J. Med. - 2003

Manuscript - Primary - Primary - GI - CALGB-9270

Repeated Measures Analyses of Dermatitis Symptom Evolution in Breast Cancer Patients Receiving Radiotherapy in a Phase 3 Randomized Trial of Mometasone Furoate vs Placebo (N06C4 [Alliance])

Sio, Terence T. , Atherton, Pamela J. , Birckhead, Brandon J ... - - Support Care Cancer - 2016

Manuscript - Secondary - Primary - Symptom Inter - N06C4

Effect of Doxepin Mouthwash or Diphenhydramine-Lidocaine-Antacid Mouthwash vs Placebo on Radiotherapy-Related Oral Mucositis Pain

Sio, Terence T. , Le-Rademacher, Jennifer G. , Leenstra, James L. ... - - JAMA - 2019

Manuscript - Primary - Primary - Symptom Inter - A221304

A patient-level pooled analysis of the prognostic significance of baseline fatigue for overall survival (OS) among 3,915 patients participating in 43 North Central Cancer Treatment Group (NCCTG) and Mayo Clinic Cancer Center (MC) oncology clinical trials.

Sloan, J. A. , Liu, H. , Sargent, D. J. , Satele, D. , Schaefer, P. L. ... - - J. Clin. Oncol. - 2009

Abstract - Secondary-not-in-original - Primary - Health Outcome - Comprehensive

Rasch model-based testing of the European Organisation for Research and Treatment of Cancer (EORTC) Quality of Life Questionnaire–Chemotherapy-Induced Peripheral Neuropathy (QLQ-CIPN20) using Alliance for Clinical Trials in Oncology (Alliance) A151408 study data

Smith, Ellen M. Lavoie , Zanville, Noah , Kanzawa-Lee, Grace ... - - Support Care Cancer - 2019

Manuscript - Primary - Primary - Symptom Inter - A151408 , N06CA , N08C1 , N08CA , N08CB

Multisite, Randomized Trial of Early Integrated Palliative and Oncology Care in Patients with Advanced Lung and Gastrointestinal Cancer: Alliance A221303

Temel, Jennifer S. , Sloan, Jeff , Zemla, Tyler , Greer, Joseph A. ... - - J Palliat Med - 2020

Manuscript - Primary - Primary - Symptom Inter - A221303

A novel approach of longitudinal adverse event evaluation in oncology clinical trials: the Toxicity over Time (ToxT) analysis of clinical trials N9741 and 979254 (Alliance)

Thanarajasingam, Gita , Atherton, Pamela J. , Novotny, Paul J. ... - - Lancet Oncol. - 2016

Manuscript - Secondary-not-in-original - Primary - Health Outcome - N9741 , NCCTG-97-92-54

5-year Follow-up of a Randomized Controlled Trial of Immediate versus Delayed Zoledronic Acid for Prevention of Bone Loss in Postmenopausal Women with Breast Cancer Starting Letrozole after Tamoxifen: N03CC (Alliance)

Wagner-Johnston, Nina D. , Sloan, Jeff A. , Liu, Heshan ... - - Cancer - 2015

Manuscript - Primary - Long-Term-Followup - Symptom Inter - N03CC

The relationship between numbness, tingling, and shooting/burning pain in patients with chemotherapy-induced peripheral neuropathy (CIPN) as measured by the EORTC QLQ-CIPN20 instrument, N06CA

Wolf, S. L. , Barton, D. L. , Qin, R. , Wos, E. J. , Sloan, J. A. ... - - Support Care Cancer - 2012

Manuscript - Secondary - Primary - Health Outcome - N06CA

Relationship of sensory symptoms and motor function in patients with chemotherapy-induced peripheral neuropathy (CIPN) utilizing the EORTC QLQ CIPN20: NCCTG study N06CA

Wolf, S. L. , Qin, R. , Barton, D. L. , Sloan, J. A. , Liu, H. ... - - J. Clin. Oncol. - 2009

Abstract - Secondary - Primary - Health Outcome - N06CA

Evaluation of a urea/lactic acid-based topical keratolytic agent (ULABTKA) for prevention of capecitabine-induced hand and foot syndrome (HFS): NCCTG trial N05C5

Wolf, S. L. , Qin, R. , Menon, S. P. , Rowland, K. M., Jr ... - - J. Clin. Oncol. - 2010

Abstract - Primary - Primary - Symptom Inter - N05C5

Placebo-Controlled Trial to Determine the Effectiveness of a Urea/Lactic Acid–Based Topical Keratolytic Agent for Prevention of Capecitabine-Induced Hand-Foot Syndrome: North Central Cancer Treatment Group Study N05C5

Wolf, Sherry L. , Qin, Rui , Menon, Smitha P. , Rowland, Kendrith M. ... - - J Clin Oncol - 2010

Manuscript - Primary - Primary - Symptom Inter - N05C5

Venlafaxine to prevent oxaliplatin-induced neuropathy?: A pilot randomized placebo-controlled trial.

Zimmerman, Collin Thomas , Atherton, Pamela J. , Pachman, Deirdre R. ... - ASCO - J. Clin. Oncol. - 2015

Abstract - Primary - Primary - Symptom Inter - NCT01611155

Venlafaxine to Prevent Oxaliplatin-Induced Neuropathy? A Pilot Randomized Placebo Controlled Trial

Zimmerman, Collin , Atherton, Pam , Pachman, Deirdre , Seisler, Drew ... - MASCC / ISOO - Support Care Cancer - 2015

Abstract - Primary - Primary - Symptom Inter - NCT01611155

MC11C4: a pilot randomized, placebo-controlled, double-blind study of venlafaxine to prevent oxaliplatin-induced neuropathy

Zimmerman, Collin , Atherton, Pamela J. , Pachman, Deirdre ... - - Support Care Cancer - 2016

Manuscript - Primary - Primary - Symptom Inter - NCT01611155